(VRE) Veris Residential - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US5544891048
Stock: Multifamily, Class A, Northeast, Residential
Total Rating 33
Risk 23
Buy Signal 0.08
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 2.08% |
| Yield on Cost 5y | 2.57% |
| Yield CAGR 5y | 76.26% |
| Payout Consistency | 82.7% |
| Payout Ratio | 40.0% |
| Risk 5d forecast | |
|---|---|
| Volatility | 21.1% |
| Relative Tail Risk | -0.33% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.17 |
| Alpha | -4.31 |
| Character TTM | |
|---|---|
| Beta | 0.497 |
| Beta Downside | 0.545 |
| Drawdowns 3y | |
|---|---|
| Max DD | 29.43% |
| CAGR/Max DD | 0.07 |
Description: VRE Veris Residential January 15, 2026
Veris Residential, Inc. (NYSE: VRE) is a REIT focused on acquiring, developing, and managing Class A multifamily assets in the Northeast United States. The firm emphasizes a technology-enabled, vertically integrated operating model that aims to deliver modern living experiences while fostering community impact, guided by an experienced leadership team and strong corporate-governance practices.
Key operational metrics as of Q4 2023 show an occupancy rate of roughly 96 % and average rent growth of about 4 % year-over-year, outpacing the national multifamily average of ~2.5 %. The company’s pipeline includes roughly 2.5 million sq ft of under-development projects, positioning it to benefit from the Northeast’s robust job market and constrained housing supply-both drivers of sustained rent inflation. However, VRE’s performance remains sensitive to rising interest rates, which can pressure cap rates and refinancing costs.
For a deeper quantitative assessment, the ValueRay platform offers granular REIT metrics and scenario analysis that can help you evaluate VRE’s risk-adjusted upside.
Piotroski VR‑10 (Strict, 0-10) 2.0
| Net Income: 63.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA 0.19 > 1.0 |
| NWC/Revenue: -27.37% < 20% (prev -126.1%; Δ 98.75% < -1%) |
| CFO/TA 0.02 > 3% & CFO 67.3m > Net Income 63.0m |
| Net Debt (1.42b) to EBITDA (239.9m): 5.94 < 3 |
| Current Ratio: 0.28 > 1.5 & < 3 |
| Outstanding Shares: last quarter (102.5m) vs 12m ago 0.89% < -2% |
| Gross Margin: 59.66% > 18% (prev 0.59%; Δ 5907 % > 0.5%) |
| Asset Turnover: 9.84% > 50% (prev 9.00%; Δ 0.84% > 0%) |
| Interest Coverage Ratio: 1.65 > 6 (EBITDA TTM 239.9m / Interest Expense TTM 93.1m) |
Altman Z'' -2.46
| A: -0.03 (Total Current Assets 30.0m - Total Current Liabilities 108.1m) / Total Assets 2.79b |
| B: -0.51 (Retained Earnings -1.41b / Total Assets 2.79b) |
| C: 0.05 (EBIT TTM 153.9m / Avg Total Assets 2.90b) |
| D: -0.94 (Book Value of Equity -1.41b / Total Liabilities 1.51b) |
| Altman-Z'' Score: -2.46 = D |
Beneish M 1.00
| DSRI: 1.01 (Receivables 4.22m/3.94m, Revenue 285.2m/270.4m) |
| GMI: 0.99 (GM 59.66% / 58.79%) |
| AQI: 22.81 (AQ_t 0.99 / AQ_t-1 0.04) |
| SGI: 1.05 (Revenue 285.2m / 270.4m) |
| TATA: -0.00 (NI 63.0m - CFO 67.3m) / TA 2.79b) |
| Beneish M-Score: 9.95 (Cap -4..+1) = D |
What is the price of VRE shares?
As of February 07, 2026, the stock is trading at USD 16.64 with a total of 1,789,103 shares traded.
Over the past week, the price has changed by +9.55%, over one month by +11.16%, over three months by +13.49% and over the past year by +5.33%.
Over the past week, the price has changed by +9.55%, over one month by +11.16%, over three months by +13.49% and over the past year by +5.33%.
Is VRE a buy, sell or hold?
Veris Residential has received a consensus analysts rating of 3.67.
Therefor, it is recommend to hold VRE.
- StrongBuy: 2
- Buy: 0
- Hold: 4
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the VRE price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 17.6 | 5.6% |
| Analysts Target Price | 17.6 | 5.6% |
| ValueRay Target Price | 16.5 | -0.6% |
VRE Fundamental Data Overview February 03, 2026
P/E Trailing = 24.1111
P/S = 5.7698
P/B = 1.2178
Revenue TTM = 285.2m USD
EBIT TTM = 153.9m USD
EBITDA TTM = 239.9m USD
Long Term Debt = 1.40b USD (from longTermDebt, last quarter)
Short Term Debt = 31.0m USD (from shortTermDebt, last quarter)
Debt = 1.43b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.42b USD (from netDebt column, last quarter)
Enterprise Value = 3.11b USD (1.68b + Debt 1.43b - CCE 8.78m)
Interest Coverage Ratio = 1.65 (Ebit TTM 153.9m / Interest Expense TTM 93.1m)
EV/FCF = 60.04x (Enterprise Value 3.11b / FCF TTM 51.7m)
FCF Yield = 1.67% (FCF TTM 51.7m / Enterprise Value 3.11b)
FCF Margin = 18.14% (FCF TTM 51.7m / Revenue TTM 285.2m)
Net Margin = 22.09% (Net Income TTM 63.0m / Revenue TTM 285.2m)
Gross Margin = 59.66% ((Revenue TTM 285.2m - Cost of Revenue TTM 115.0m) / Revenue TTM)
Gross Margin QoQ = 59.72% (prev 61.56%)
Tobins Q-Ratio = 1.11 (Enterprise Value 3.11b / Total Assets 2.79b)
Interest Expense / Debt = 1.55% (Interest Expense 22.2m / Debt 1.43b)
Taxrate = 0.05% (35.0k / 77.6m)
NOPAT = 153.8m (EBIT 153.9m * (1 - 0.05%))
Current Ratio = 0.28 (Total Current Assets 30.0m / Total Current Liabilities 108.1m)
Debt / Equity = 1.24 (Debt 1.43b / totalStockholderEquity, last quarter 1.16b)
Debt / EBITDA = 5.94 (Net Debt 1.42b / EBITDA 239.9m)
Debt / FCF = 27.54 (Net Debt 1.42b / FCF TTM 51.7m)
Total Stockholder Equity = 1.11b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.17% (Net Income 63.0m / Total Assets 2.79b)
RoE = 5.70% (Net Income TTM 63.0m / Total Stockholder Equity 1.11b)
RoCE = 6.14% (EBIT 153.9m / Capital Employed (Equity 1.11b + L.T.Debt 1.40b))
RoIC = 5.60% (NOPAT 153.8m / Invested Capital 2.75b)
WACC = 4.89% (E(1.68b)/V(3.11b) * Re(7.74%) + D(1.43b)/V(3.11b) * Rd(1.55%) * (1-Tc(0.00)))
Discount Rate = 7.74% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 5.41%
[DCF Debug] Terminal Value 80.82% ; FCFF base≈51.1m ; Y1≈33.5m ; Y5≈15.3m
Fair Price DCF = N/A (negative equity: EV 487.4m - Net Debt 1.42b = -937.3m; debt exceeds intrinsic value)
[DCF Warning] FCF declining rapidly (-40.0%), DCF may be unreliable
EPS Correlation: 36.77 | EPS CAGR: 3.37% | SUE: 0.20 | # QB: 0
Revenue Correlation: -31.60 | Revenue CAGR: -4.78% | SUE: -0.04 | # QB: 0
EPS next Quarter (2026-03-31): EPS=-0.11 | Chg30d=+0.000 | Revisions Net=-1 | Analysts=1
EPS next Year (2026-12-31): EPS=-0.23 | Chg30d=+0.014 | Revisions Net=+1 | Growth EPS=-134.1% | Growth Revenue=-1.4%
P/S = 5.7698
P/B = 1.2178
Revenue TTM = 285.2m USD
EBIT TTM = 153.9m USD
EBITDA TTM = 239.9m USD
Long Term Debt = 1.40b USD (from longTermDebt, last quarter)
Short Term Debt = 31.0m USD (from shortTermDebt, last quarter)
Debt = 1.43b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.42b USD (from netDebt column, last quarter)
Enterprise Value = 3.11b USD (1.68b + Debt 1.43b - CCE 8.78m)
Interest Coverage Ratio = 1.65 (Ebit TTM 153.9m / Interest Expense TTM 93.1m)
EV/FCF = 60.04x (Enterprise Value 3.11b / FCF TTM 51.7m)
FCF Yield = 1.67% (FCF TTM 51.7m / Enterprise Value 3.11b)
FCF Margin = 18.14% (FCF TTM 51.7m / Revenue TTM 285.2m)
Net Margin = 22.09% (Net Income TTM 63.0m / Revenue TTM 285.2m)
Gross Margin = 59.66% ((Revenue TTM 285.2m - Cost of Revenue TTM 115.0m) / Revenue TTM)
Gross Margin QoQ = 59.72% (prev 61.56%)
Tobins Q-Ratio = 1.11 (Enterprise Value 3.11b / Total Assets 2.79b)
Interest Expense / Debt = 1.55% (Interest Expense 22.2m / Debt 1.43b)
Taxrate = 0.05% (35.0k / 77.6m)
NOPAT = 153.8m (EBIT 153.9m * (1 - 0.05%))
Current Ratio = 0.28 (Total Current Assets 30.0m / Total Current Liabilities 108.1m)
Debt / Equity = 1.24 (Debt 1.43b / totalStockholderEquity, last quarter 1.16b)
Debt / EBITDA = 5.94 (Net Debt 1.42b / EBITDA 239.9m)
Debt / FCF = 27.54 (Net Debt 1.42b / FCF TTM 51.7m)
Total Stockholder Equity = 1.11b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.17% (Net Income 63.0m / Total Assets 2.79b)
RoE = 5.70% (Net Income TTM 63.0m / Total Stockholder Equity 1.11b)
RoCE = 6.14% (EBIT 153.9m / Capital Employed (Equity 1.11b + L.T.Debt 1.40b))
RoIC = 5.60% (NOPAT 153.8m / Invested Capital 2.75b)
WACC = 4.89% (E(1.68b)/V(3.11b) * Re(7.74%) + D(1.43b)/V(3.11b) * Rd(1.55%) * (1-Tc(0.00)))
Discount Rate = 7.74% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 5.41%
[DCF Debug] Terminal Value 80.82% ; FCFF base≈51.1m ; Y1≈33.5m ; Y5≈15.3m
Fair Price DCF = N/A (negative equity: EV 487.4m - Net Debt 1.42b = -937.3m; debt exceeds intrinsic value)
[DCF Warning] FCF declining rapidly (-40.0%), DCF may be unreliable
EPS Correlation: 36.77 | EPS CAGR: 3.37% | SUE: 0.20 | # QB: 0
Revenue Correlation: -31.60 | Revenue CAGR: -4.78% | SUE: -0.04 | # QB: 0
EPS next Quarter (2026-03-31): EPS=-0.11 | Chg30d=+0.000 | Revisions Net=-1 | Analysts=1
EPS next Year (2026-12-31): EPS=-0.23 | Chg30d=+0.014 | Revisions Net=+1 | Growth EPS=-134.1% | Growth Revenue=-1.4%